Bellemore, S M <br/><br/>
Anti-atherogenic peptide Ep1.B derived from apolipoprotein E induces tolerogenic plasmacytoid dendritic cells.  [electronic resource] 

 -  Clinical and experimental immunology  Sep 2014 
 - 732-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2249 
<br/><br/><label>Standard No.: </label>10.1111/cei.12370  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adoptive Transfer<br/>Animals<br/>Apolipoproteins E--administration & dosage<br/>CD11c Antigen--metabolism<br/>Cell Differentiation--drug effects<br/>Cell Line<br/>Dendritic Cells--cytology<br/>Female<br/>Humans<br/>Immune Tolerance--drug effects<br/>Immunophenotyping<br/>Injections, Intraperitoneal<br/>Interferon-alpha--biosynthesis<br/>Mice<br/>Mice, Inbred NOD<br/>Peptide Fragments--administration & dosage<br/>Phenotype<br/>Spleen--cytology<br/>T-Lymphocyte Subsets--immunology